mRNA-based gene transfer as a tool for gene and cell therapy.
about
Pathogen-Associated Molecular Patterns Induced Crosstalk between Dendritic Cells, T Helper Cells, and Natural Killer Helper Cells Can Improve Dendritic Cell VaccinationProgress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseasesActive specific immunotherapy targeting the Wilms' tumor protein 1 (WT1) for patients with hematological malignancies and solid tumors: lessons from early clinical trialspiggyBac transposon/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies.Reporter gene-expressing bone marrow-derived stromal cells are immune-tolerated following implantation in the central nervous system of syngeneic immunocompetent mice.Induction of cytotoxic T lymphocytes primed with tumor RNA-loaded dendritic cells in esophageal squamous cell carcinoma: preliminary step for DC vaccine design.Protein transduction from retroviral Gag precursorsEfficient, high-throughput transfection of human embryonic stem cellsA short pulse of IL-4 delivered by DCs electroporated with modified mRNA can both prevent and treat autoimmune diabetes in NOD mice.A Simple, Highly Efficient Method for Heterologous Expression in Mammalian Primary Neurons Using Cationic Lipid-mediated mRNA Transfection.In vivo messenger RNA introduction into the central nervous system using polyplex nanomicelle.Optimization of the piggyBac transposon using mRNA and insulators: toward a more reliable gene delivery system.Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer.Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cellsIncorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.Targeting lentiviral vectors for cancer immunotherapy.Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.A method for stabilizing RNA for transfection that allows control of expression duration.Evaluation of RNA Amplification Methods to Improve DC Immunotherapy Antigen Presentation and Immune ResponseT cells engineered with a cytomegalovirus-specific chimeric immunoreceptor.Characterization of Interleukin-15-Transpresenting Dendritic Cells for Clinical Use.A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen-specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells.Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory propertiesAntitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials.The Impact of Metallic Nanoparticles on Stem Cell Proliferation and Differentiation
P2860
Q26765345-3434D35B-2430-4703-9959-B3346FC4C859Q27011249-90E1F376-3E26-47D7-BB8D-8CA056999751Q27026836-08B5CAE5-B688-4B09-B147-DF14150A48E4Q30496580-B09DB6E0-A4B4-46AB-8428-26A470B8FB2AQ33398144-1658931A-4FC0-4E33-BD80-AC59FA4414ABQ33595455-A2DFC84C-93C7-4642-819F-7D277871D7AAQ33842785-375040ED-8F98-44D4-9FFE-E385854F3FF0Q34135224-A66C1A59-7A9C-4A0E-ADF0-A0D79D381173Q34382930-62C01AF0-88B8-45B2-89EB-24EE626968B1Q34508332-AC62CB81-EC1D-41C9-A411-170CA23851BCQ34589906-DA45FEE1-11F3-4512-BA17-A6083E65C170Q35061551-D782E2C9-B17D-4F45-99F4-3187CEE8CD8DQ36485047-DC3A4059-6A3F-49CB-8452-B912FD9EAF3CQ36673747-64CABE96-20D7-4C16-9D91-28087C7987B0Q37403787-C15B91C0-7745-4201-AF68-442E7A4D645AQ37416925-5C3B09C7-9C51-4AAE-8EC4-C41966124EFAQ37621566-8D2FCDC6-9757-4860-B126-841A43744785Q38043924-EEA1A549-9A8A-4ED7-8EC3-7ABD3BF4AFE2Q39015531-E189F4C5-0CE1-463B-901B-1453700F025CQ39692864-748D791C-925F-4C78-B11F-F661F370F43CQ39791507-B5D7D5EA-3F41-419F-84D1-DA7887B96D94Q39898534-9616461C-04CF-4D09-81E2-5BE62D262ACBQ40102608-D635D71E-ED63-4AAF-BA52-7391D3777D8DQ41867724-DB18472B-E4F4-4034-B12D-611706727AA6Q41945985-58D39726-9076-4379-8E1B-B4A0FCB3C843Q42925679-226747E7-4092-473A-AFF0-B67BF2DFA8F3Q59133680-F3B0235C-B221-4D84-B55E-51CAEFC34292
P2860
mRNA-based gene transfer as a tool for gene and cell therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
mRNA-based gene transfer as a tool for gene and cell therapy.
@en
type
label
mRNA-based gene transfer as a tool for gene and cell therapy.
@en
prefLabel
mRNA-based gene transfer as a tool for gene and cell therapy.
@en
P1476
mRNA-based gene transfer as a tool for gene and cell therapy
@en
P2093
Viggo F I Van Tendeloo
P304
P577
2007-10-01T00:00:00Z